Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).

被引：0
|
作者：
Sarkaria, Jann Nagina
Ballman, Karla V.
Kizilbash, Sani Haider
Sulman, Erik P.
Giannini, Caterina
Mashru, Sandeep H.
Piccioni, David Eric
Friday, Bret Edward Buckley
Dixon, Jesse G.
Kabat, Brian
Laack, Nadia N.
Hu, Leland
Kumthekar, Priya
Ellingson, Benjamin M.
Anderson, S. Keith
Galanis, Evanthia
机构：
[1] Mayo Clin, Rochester, MN USA
[2] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA
[3] Mayo Clin, Div Med Oncol, Rochester, MN USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] NW Kaiser Permanente, Portland, OR USA
[6] Univ Calif San Diego, Moores Canc Ctr, Ctr Personalized Canc Therapy, San Diego, CA USA
[7] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, San Diego, CA USA
[8] SMDC, Duluth, MN USA
[9] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[10] Mayo Clin, Phoenix, AZ USA
[11] Univ Chicago, Alliance Protocol Operat Off, Chicago, IL USA
[12] Univ Calif Los Angeles, Brain Res Inst, Dept Radiol, Radiol, Los Angeles, CA USA
[13] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2001
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A PHASE II TRIAL OF CONCURRENT SUNITINIB, TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS WITH AN UNMETHYLATED MGMT GENE PROMOTER (A01-M121-11A, MCG1132)
    Faye, Mame Daro
    Sabri, Siham
    De Robles, Paula
    Easaw, Jacob
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Abdulkarim, Bassam
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S5 - S5
  • [32] RTOG 0525: Molecular correlates from randomized phase III trial of newly diagnosed glioblastoma (GBM).
    Aldape, K. D.
    Wang, M.
    Sulman, E. P.
    Cahill, D. P.
    Hegi, M.
    Colman, H.
    Jones, G.
    Chakravarti, A.
    Mehta, M. P.
    Andrews, D. W.
    Long, L.
    Diefes, K.
    Heathcock, L.
    Jenkins, R.
    Schultz, C. J.
    Gilbert, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Sarris, G
    Beroukas, K
    Karageorgis, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
  • [34] Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
    Thivat, Emilie
    Casile, Melanie
    Moreau, Juliette
    Molnar, Ioana
    Dufort, Sandrine
    Seddik, Khalide
    Le Duc, Geraldine
    De Beaumont, Olivier
    Loeffler, Markus
    Durando, Xavier
    Biau, Julian
    BMC CANCER, 2023, 23 (01)
  • [35] Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
    Emilie Thivat
    Mélanie Casile
    Juliette Moreau
    Ioana Molnar
    Sandrine Dufort
    Khalide Seddik
    Géraldine Le Duc
    Olivier De Beaumont
    Markus Loeffler
    Xavier Durando
    Julian Biau
    BMC Cancer, 23
  • [36] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [37] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Thomas, Alissa A.
    Beal, Kathryn
    McNeill, Katharine Anne
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Perez, Julio Arevalo
    Yamada, Yoshiya
    Anderson, Barry Douglas
    Lamson, Michael
    Burch, Brandon
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Omuro, Antonio Marcilio Padula
    Beal, Kathryn
    McNeill, Katharine Anne
    Thomas, Alissa A.
    Lin, Xuling
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Yamada, Yoshiya
    Gorman, Greg
    Lamson, Michael
    Bavisotto, Linda M.
    Karmali, Rashida A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM).
    Quant, E. C.
    Batchelor, T.
    Lassman, A. B.
    Schiff, D.
    Kaley, T. J.
    Wong, E.
    Mikkelsen, T.
    Drappatz, J.
    Norden, A. D.
    Beroukhim, R.
    Weiss, S. E.
    Alexander, B. M.
    Sceppa, C.
    Gerard, M.
    Hallisey, S. D.
    Bochacki, C. A.
    Smith, K. H.
    Muzikansky, A.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study
    Nicholas, M. K.
    Lucas, R. V.
    Arzbaecher, J.
    Paleologos, N.
    Krouwer, H.
    Malkin, M.
    Omar, A.
    Vick, N. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345